An Observational Post-Authorization Safety Study (PASS) of MOVENTIG® (Naloxegol) Drug Utilization in Selected European Populations

First published 03/03/2016

Last updated 02/07/2024

EU PAS number:

EUPAS12598

Study

Finalised

Documents

Study protocol

Initial protocol

D3820R00006 CSP - PRAC 01212015 final

English (331.4 KB - PDF) View document

Updated protocol

D3820R00006 CSP - PRAC 01212015 final_ppd OK

First published: 22/02/2024

English (335.3 KB - PDF) View document

Study results

Naloxegol DU Report_Final_V1.0_clean_15July2021_Abstract

English (517.48 KB - PDF) View document

Study report

Other information

Secondary tabs